Genomic Test Does Not Increase Active Surveillance Acceptance for Treating Favorable-Risk Prostate Cancer
The results from a trial evaluating the Genomic Prostate Score did not find an increase in active surveillance acceptance amongst... Read More
Focal Ablation Technique for Intermediate-Risk Prostate Cancer Continues to Show Safety
The NanoTherm therapy system for focal ablation of intermediate-risk prostate cancer continued to show a tolerable safety profile in a... Read More
Treatment Targeting Is Key to Success in Oncology
With precision-guided approaches to care establishing themselves across tumor types, newer systemic therapy regimens are almost exclusively developed for the... Read More
Black Men with Prostate Cancer Treated with Radiation in VA Health System See Improved Outcomes
Black race was associated with improved prostate cancer-specific mortality and all-cause mortality among men with nonmetastatic prostate cancer who received... Read More
Men With Advanced Prostate Cancer, Be Informed About Your Genetics!
In this video, Dr. Heather Cheng briefly outlines the GENTleMEN study of the impact of genetic testing for men with advanced... Read More
Adjuvant Docetaxel Fails in Higher-Risk Prostate Cancer
Adjuvant docetaxel without prednisone failed to improve biochemical disease-free survival in men with intermediate- or high-risk prostate cancer who have... Read More
Smoking at Time of Treatment Worsens Prostate Cancer Outcomes
Current smokers at the time of primary treatment for localized prostate cancer have a higher risk of negative outcomes, including... Read More
Abiraterone May Be More Effective in Black Men With Prostate Cancer
Black men with metastatic castration-resistant prostate cancer (CRPC) who received hormonal therapy with the adrenal inhibitor abiraterone had greater and... Read More
Initiation of ADT in a Man With Locally Advanced Prostate Cancer and Multiple Cardiovascular Risk Factors
The case: A 65-year-old man presented with locally advanced, high-risk prostate cancer. He shad type 2 diabetes, he was also overweight... Read More
Whole-Genome Analyses Expand Genetic Picture of Prostate Cancer
Researchers have found a number of previously unidentified genes that may act as drivers of prostate cancer. A new study... Read More